anthrax-post-exposure-prophylaxis-library
type: Library
node role: treeRoot
id:
  v: anthrax-post-exposure-prophylaxis-library
text:
  status:
    v: generated
  div: Generated Narrative: Library anthrax-post-exposure-prophylaxis-library Participants Author Alliance to Modernize Healthcare FFRDC Endorser Centers for Disease Control and Prevention Contents text/cql /* Library: Anthrax Post Exposure Prophylaxis (PEP) for Adults, FHIR R4 data model. Author: CMS Alliance to Modernize Healthcare, operated by THE MITRE Corporation. (C) 2019 The MITRE Corporation. All Rights Reserved. Approved for Public Release: 19-2048. Distribution Unlimited. Change log: - Version 1.1.0: Updated output resources to align with draft profiles posted at: http://build.fhir.org/ig/HL7/cqf-recommendations/profiles.html Also refactored CQL to put CDC-specific functions in a seperate library. */ library Anthrax_Post_Exposure_Prophylaxis_Adults_FHIRv400 version '1.1.0' /* ------------- REFERENCES ---------------------------------------------------- - Hendricks, K.A. et al., Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults. Emerg Infect Dis, 20(20), Feb 2014. - Hendricks, K.A. et al., Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults: Technical Report. Emerg Infect Dis. 20(20), Feb 2014. - Emergent BioSolutions, BioThrax Anthrax Vaccine Adsorbed (http://www.biothrax.com/whatisbiothrax/). - Centers for Disease Control and Prevention, Ciprofloxacin for Post-Exposure Prophylaxis of Anthrax: Emergency Use Instructions for Healthcare Providers, 2017. - Centers for Disease Control and Prevention. Doxycyxcline for Post-Exposure Prophylaxis of Anthrax: Emergency Use Instructions for Healthcare Providers, 2017. - Public Health Information Network Vocabulary Access and Distribution System (PHIN VADS), PHVS_SignsSymptoms_Anthrax (OID 2.16.840.1.114222.4.11.3212), 2009. - Meanye-Delman D et al., Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women, Emerg Infect Dis, 20(2), 2014. - Meanye-Delman D e…
url:
  v: http://cqframework.org/cpg-example-anthrax/Library/anthrax-post-exposure-prophylaxis-library
identifier:
  use:
    v: official
  value:
    v: Anthrax_Post_Exposure_Prophylaxis_FHIRv400
version:
  v: 1.1.0
name:
  v: Anthrax_Post_Exposure_Prophylaxis_FHIRv400_Library
title:
  v: Anthrax Post Exposure Prophylaxis (PEP) for Adults FHIRv400 Logic
status:
  v: draft
experimental:
  v: true
type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/library-type
    code:
      v: logic-library
date:
  v: 2024-11-18T16:43:41+00:00
publisher:
  v: HL7 International - Clinical Decision Support WG
contact:
  name:
    v: HL7 International - Clinical Decision Support WG
  telecom:
    system:
      v: url
    value:
      v: http://www.hl7.org/Special/committees/dss/index.cfm
description:
  v: Clinical decision support logic for Anthrax Post Exposure Prophylaxis (PEP) for Adults based on the following Centers for Disease Control and Prevention reports: \n- Hendricks, K.A. et al., Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults. Emerg Infect Dis, 20(20), Feb 2014. \n - Hendricks, K.A. et al., Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults: Technical Report. Emerg Infect Dis. 20(20), Feb 2014. \n- Emergent BioSolutions, BioThrax Anthrax Vaccine Adsorbed (http://www.biothrax.com/whatisbiothrax/). \n- Centers for Disease Control and Prevention, Ciprofloxacin for Post-Exposure Prophylaxis of Anthrax: Emergency Use Instructions for Healthcare Providers, 2017. \n- Centers for Disease Control and Prevention. Doxycyxcline for Post-Exposure Prophylaxis of Anthrax: Emergency Use Instructions for Healthcare Providers, 2017. \n- Public Health Information Network Vocabulary Access and Distribution System (PHIN VADS), PHVS_SignsSymptoms_Anthrax (OID 2.16.840.1.114222.4.11.3212), 2009. \n- Meanye-Delman D et al., Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women, Emerg Infect Dis, 20(2), 2014. \n- Meanye-Delman D et al., Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women: Technical Report, Emerg Infect Dis, 20(2), 2014. \n- Wright, J.G et al., Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, Morbidity and Mortality Weeklly Report, July 23, 2010 / 59(RR06); 1-30.
use context:
  code:
    system:
      v: http://terminology.hl7.org/CodeSystem/usage-context-type
    code:
      v: age
    display:
      v: Age Range
  value: Range
    low:
      value:
        v: 18
use context:
  code:
    system:
      v: http://terminology.hl7.org/CodeSystem/usage-context-type
    code:
      v: venue
    display:
      v: Clinical Venue
  value: CodeableConcept
    coding: http://snomed.info/id/440655000
      system:
        v: http://snomed.info/sct
      code:
        v: 440655000
      display:
        v: Outpatient environment
use context:
  code:
    system:
      v: http://terminology.hl7.org/CodeSystem/usage-context-type
    code:
      v: focus
    display:
      v: Clinical Focus
  value: CodeableConcept
    coding:
      system:
        v: http://hl7.org/fhir/sid/icd-10-cm
      code:
        v: Z20.810
      display:
        v: Contact with and (suspected) exposure to anthrax
use context:
  code:
    system:
      v: http://terminology.hl7.org/CodeSystem/usage-context-type
    code:
      v: focus
    display:
      v: Clinical Focus
  value: CodeableConcept
    coding: http://snomed.info/id/170475009
      system:
        v: http://snomed.info/sct
      code:
        v: 170475009
      display:
        v: Exposure to Bacillus anthracis (event)
use context:
  code:
    system:
      v: http://terminology.hl7.org/CodeSystem/usage-context-type
    code:
      v: focus
    display:
      v: Clinical Focus
  value: CodeableConcept
    coding: http://snomed.info/id/84387000
      system:
        v: http://snomed.info/sct
      code:
        v: 84387000
      display:
        v: Asymptomatic (finding)
jurisdiction:
  coding:
    system:
      v: http://unstats.un.org/unsd/methods/m49/m49.htm
    code:
      v: 001
    display:
      v: World
purpose:
  v: Provides clinicians with information for quickly assessing individuals exposed to anthrax unrelated to occupational exposure, for example in bioterrorism events, and provides the recommended post-exposure prophylaxis (PEP) regimen for asymptomatic patients. Includes immediate treatment with antimicrobials and vaccine and follow-up administration of subsequent vaccines to complete the recommended 3-dose vaccination series.
usage:
  v: Intended for use by clinicians caring for individuals ≥18 years of age in an outpatient setting.
topic:
  text:
    v: Anthrax
topic:
  text:
    v: Emergency Medicine
topic:
  text:
    v: Post-Exposure Prophylaxis
author:
  name:
    v: Alliance to Modernize Healthcare FFRDC
endorser:
  name:
    v: Centers for Disease Control and Prevention
content:
  content type:
    v: text/cql
content:
  content type:
    v: application/elm+xml